Temporal effects of catalase overexpression on healing after myocardial infarction

Circulation: Heart Failure

Volumn 4, Issue 1, 2011, Pages 98-106

  Pendergrass, Karl D ^a,b   Varghese, Susan T ^a,b   Maiellaro Rafferty, Kathryn ^a,b   Brown, Milton E ^a,b   Taylor, W Robert ^a,b,c,d   Davis, Michael E ^a,b,c  

^a Wallace H Coulter Department of Biomedical Engineering   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Affairs Medical Center   (United States)

Author keywords

Catalase; Hydrogen peroxides; Myocardial infarction; Oxidative stress

Indexed keywords

CATALASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROGEN PEROXIDE; SCAVENGER; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEALING; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR; ANIMAL; CONVALESCENCE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MALE; METABOLISM; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CATALASE; COLLAGEN TYPE I; COLLAGEN TYPE III; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOVERY OF FUNCTION; TAMOXIFEN;

EID: 79952257682     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.957712     Document Type: Article

References (37)

1. Li G, Chen Y, Saari JT, Kang YJ. Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury. Am J Physiol. 1997;273:H1090-H1095.
2. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, Bristow MR, Colucci WS, Sawyer DB. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail. 2005;11:473-480.
3. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009;105:1164-1176.
4. Khaper N, Kaur K, Li T, Farahmand F, Singal PK. Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem. 2003;251:9-15. (Pubitemid 37220703)
5. Ozdemir R, Parlakpinar H, Polat A, Colak C, Ermis N, Acet A. Selective endothelin a (eta) receptor antagonist (bq-123) reduces both myocardial infarct size and oxidant injury. Toxicology. 2006;219:142-149. (Pubitemid 43120714)
6. Zhu YZ, Chong CL, Chuah SC, Huang SH, Tong HT, Nai HS, Whiteman ML, Moore PK. Cardioprotective effects of nitroparacetamol and paracetamol in the acute phase of myocardial infarction in experimental rats. Am J Physiol Heart Circ Physiol. 2006;290:H517-H524.
7. Kang YJ, Chen Y, Epstein PN. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem. 1996;271:12610-12616. (Pubitemid 26160936)
8. Jeroudi MO, Triana FJ, Patel BS, Bolli R. Effect of superoxide dismutase and catalase, given separately, on myocardial "stunning." Am J Physiol. 1990;259:H889-H901. (Pubitemid 20310496)
9. Tang XL, Qiu Y, Turrens JF, Sun JZ, Bolli R. Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. Am J Physiol. 1997;273:H1651-H1657.
10. Auyeung Y, Sievers RE, Weng D, Barbosa V, Wolfe CL. Catalase inhibition with 3-amino-1,2,4-triazole does not abolish infarct size reduction in heat-shocked rats. Circulation. 1995;92:3318-3322.
11. Zhang Y, Griendling KK, Dikalova A, Owens GK, Taylor WR. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived h2o2. Hypertension. 2005;46: 732-737. (Pubitemid 43186746)
12. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J, Lee RT. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007;13:970-974. (Pubitemid 47222045)
13. Seshadri G, Sy JC, Brown M, Dikalov S, Yang SC, Murthy N, Davis ME. The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemiareperfusion injury. Biomaterials. 2010;31:1372-1379.
14. Sy JC, Seshadri G, Yang SC, Brown M, Oh T, Dikalov S, Murthy N, Davis ME. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater. 2008;7:863-868.
15. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA. Avoidance of transient cardiomyopathy in cardiomyocyte- targeted tamoxifen-induced mercremer gene deletion models. Circ Res. 2009;105:12-15.
16. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after GD-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 2001;104:2838-2842. (Pubitemid 33126660)
17. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissuespecific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible cre protein. Circ Res. 2001;89:20-25. (Pubitemid 34135487)
18. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med. 2000;109:315-323.
19. Wu S, Li Q, Du M, Li SY, Ren J. Cardiac-specific overexpression of catalase prolongs lifespan and attenuates ageing-induced cardiomyocyte contractile dysfunction and protein damage. Clin Exp Pharmacol Physiol. 2007;34:81-87. (Pubitemid 46069590)
20. Dong F, Fang CX, Yang X, Zhang X, Lopez FL, Ren J. Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity. Diabetologia. 2006;49:1421-1433.
21. Murdoch CE, Zhang M, Cave AC, Shah AM. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res. 2006;71:208-215.
22. Turdi S, Li Q, Lopez FL, Ren J. Catalase alleviates cardiomyocyte dysfunction in diabetes: role of akt, forkhead transcriptional factor and silent information regulator 2. Life Sci. 2007;81:895-905. (Pubitemid 47374209)
23. Wolkart G, Kaber G, Kojda G, Brunner F. Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overexpression in the vascular endothelium. Pharmacol Res. 2006;54:50-56. (Pubitemid 43850824)
24. Schriner SE, Ogburn CE, Smith AC, Newcomb TG, Ladiges WC, Dolle ME, Vijg J, Fukuchi K, Martin GM. Levels of DNA damage are unaltered in mice overexpressing human catalase in nuclei. Free Radic Biol Med. 2000;29:664-673.
25. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine MRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146:419-428.
26. Kraemer R, Seligmann B, Mullane KM. Polymorphonuclear leukocytes reduce cardiac function in vitro by release of H2O2. Am J Physiol. 1990;258:H1847- H1855. (Pubitemid 20226322)
27. Matsui Y, Sadoshima J. Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol. 2004;37:477-481. (Pubitemid 38953375)
28. Park SK, Kim J, Seomun Y, Choi J, Kim DH, Han IO, Lee EH, Chung SK, Joo CK. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun. 2001;284:966-971. (Pubitemid 32924742)
29. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, Takeshita A. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation. 2003;107: 1418-1423. (Pubitemid 36350742)
30. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res. 2009;81:482-490.
31. Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, Doi M, Murakami T, Ninomiya Y, Takigawa M, Tsuji T. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol. 1998;30: 2411-2422. (Pubitemid 28549991)
32. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 1998;98:149-156. (Pubitemid 28317895)
33. Dean RG, Balding LC, Candido R, Burns WC, Cao Z, Twigg SM, Burrell LM. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem. 2005;53:1245-1256. (Pubitemid 41331123)
34. Jensen LT, Host NB. Collagen: scaffold for repair or execution. Cardiovasc Res. 1997;33:535-539. (Pubitemid 27092854)
35. Jugdutt BI, Joljart MJ, Khan MI. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation. 1996;94:94-101. (Pubitemid 126426405)
36. Elgawish A, Glomb M, Friedlander M, Monnier VM. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem. 1996;271:12964-12971. (Pubitemid 26175872)
37. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108: 1395-1403. (Pubitemid 37174420)